ezetimibe has been researched along with Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fras, Z; Mikhailidis, DP | 1 |
| Cui, CJ; Li, JJ; Li, S | 1 |
| Díaz Gómez, JM | 1 |
| Fujiwara, N; Fukami, K; Kawagoe, Y; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Ueda, S; Ueda, Y; Yamagishi, S | 1 |
| Hirano, T; Mori, Y | 1 |
| Cordy, P; Garg, AX; Gomes, T; Hackam, DG; Juurlink, DN; Mamdani, M; Manno, M; Moist, L; Parikh, CR; Paterson, JM; Wald, R; Weir, MA; Yao, Z; Zhao, YY | 1 |
| Adu, D; Altmann, P; Armitage, J; Baigent, C; Ball, S; Baxter, A; Blackwell, L; Cairns, HS; Carr, S; Collins, R; Kourellias, K; Landray, M; Leaper, C; Rogerson, M; Scoble, JE; Tomson, CR; Warwick, G; Wheeler, DC | 1 |
2 review(s) available for ezetimibe and Kidney Diseases
| Article | Year |
|---|---|
PCSK9 and its modulation.
Topics: Age Factors; Atherosclerosis; Azetidines; Cholesterol; Circadian Rhythm; Diet; Drugs, Chinese Herbal; Exercise; Ezetimibe; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Kidney Diseases; Liver Regeneration; Molecular Targeted Therapy; Proprotein Convertase 9; Proprotein Convertases; Risk Factors; Serine Endopeptidases | 2015 |
[Cardiovascular mortality in kidney transplatation].
Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Comorbidity; Coronary Angiography; Diabetes Mellitus; Dyslipidemias; Ezetimibe; Humans; Kidney Diseases; Kidney Transplantation; Myocardial Ischemia; Obesity; Postoperative Complications; Preoperative Care; Prognosis; Risk Factors | 2008 |
3 trial(s) available for ezetimibe and Kidney Diseases
| Article | Year |
|---|---|
Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease).
Topics: Aged; Anticholesteremic Agents; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Non-alcoholic Fatty Liver Disease; Simvastatin; Treatment Outcome | 2021 |
Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Anticholesteremic Agents; Arginine; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Deoxyguanosine; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acid-Binding Proteins; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Middle Aged; Proteinuria; Quinolines; Severity of Illness Index; Treatment Outcome; Triglycerides | 2010 |
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.
Topics: Anticholesteremic Agents; Azetidines; Chronic Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Kidney Diseases; Male; Middle Aged; Simvastatin | 2006 |
2 other study(ies) available for ezetimibe and Kidney Diseases
| Article | Year |
|---|---|
Ezetimibe alone or in combination with pitavastatin prevents kidney dysfunction in 5/6 nephrectomized rats fed high-cholesterol.
Topics: Animals; Anticholesteremic Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Azetidines; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Creatinine; Deoxyguanosine; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Kidney; Kidney Diseases; Kidney Function Tests; Male; Nephrectomy; Proteinuria; Quinolines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA; Triglycerides | 2012 |
New fibrate use and acute renal outcomes in elderly adults: a population-based study.
Topics: Age Factors; Aged; Anticholesteremic Agents; Azetidines; Chronic Disease; Creatinine; Dyslipidemias; Ezetimibe; Female; Fibric Acids; Glomerular Filtration Rate; Hospitalization; Humans; Kidney Diseases; Male; Randomized Controlled Trials as Topic | 2012 |